Filing Details

Accession Number:
0000891293-22-000036
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-11 16:51:10
Reporting Period:
2022-07-07
Accepted Time:
2022-07-11 16:51:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891293 Cti Biopharma Corp CTIC Pharmaceutical Preparations (2834) 911533912
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1507220 A Michael Metzger 3101 Western Avenue
Suite 800
Seattle WA 98121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-07-07 9,000 $6.50 11,121 No 4 S Direct
Common Stock Disposition 2022-07-07 5,900 $6.51 5,221 No 4 S Direct
Common Stock Disposition 2022-07-07 3,321 $6.52 1,900 No 4 S Direct
Common Stock Disposition 2022-07-07 400 $6.53 1,500 No 4 S Direct
Common Stock Disposition 2022-07-07 400 $6.54 1,100 No 4 S Direct
Common Stock Disposition 2022-07-07 1,100 $6.55 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a 10b5-1 sales plan adopted by the Reporting Person.